← All trials
NCT05048901
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2021
- Primary completion
- Aug 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Sep 17, 2021
- Last posted
- Sep 17, 2021
- Enrollment
- 49
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of TaiwanLead sponsor
- Kaohsiung Medical UniversityCollaborator
- China Medical UniversityCollaborator
- Government of TaiwanOverall official - principal investigator
- Mackay Medical CollegeCollaborator
- National Taiwan UniversityCollaborator
- Taipei Veteran General hospitalCollaborator
- Government of TaiwanCollaborator
- Changhua Christian HospitalCollaborator
- National Cheng Kung UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.